Advancing siRNA Therapeutics with Pharmacometrics: A Review of Modeling Approaches and Clinical Applications
{{output}}
Small interfering RNA (siRNA) therapeutics represent a paradigm shift in targeting previously undruggable diseases through specific gene silencing. Since the FDA's first approval of patisiran in 2018, the field has expanded rapidly, with eight approved drugs ... ...
